Skip to content

Study on the effectiveness and safety of repetitive transcranial magnetic stimulation for postoperative analgesia in patients undergoing major thoracic and abdominal surgeries?

Study on the effectiveness and safety of repetitive transcranial magnetic stimulation for postoperative analgesia in patients undergoing major thoracic and abdominal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105236
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-07-03
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia

Interventions

Test Group 1 :Preoperative active rTMS stimulation
Test Group 2:Postoperative active rTMS stimulation
Test Group 3:Preoperative or postoperative sham rTMS stimulation

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients? aged 18 to 75 years (inclusive); 2. Scheduled for ?elective major thoracic or abdominal surgery? under general anesthesia with anticipated duration of 1-4 hours; 3. Absence of ?preoperative pain? at the intended surgical site; 4. ?ASA physical status classification: Class I-III; 5. Provision of signed ?informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pre-existing ?major comorbidities? (e.g., severe cardiopulmonary insufficiency, advanced malignancy with ?anticipated life expectancy <90 days); 2. Preoperative ?major organ failure? or ?uncontrolled asthma?; 3. History of ?seizure disorders, family history of epilepsy, ?neurosurgical history, or documented ?intracranial neoplasms; ?4. Substance use disorder? within 6 months prior to screening; 5. ?Pregnancy, lactation, or parturient women; ?6. Declined participation? or ?cognitive impairment? preventing pain assessment/questionnaire completion; Current enrollment in other ?interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS Pain Score Scale;Medication Usage in Patient-Controlled Analgesia (PCA);

Secondary

MeasureTime frame
Inflammatory Cytokine Levels;Perceived Stress Scale (PSS Scale);Hospital Anxiety and Depression Scale (HADS);Quality of Recovery-15 Self-Rating Scale (QoR-15 Scale);Incidence of Surgery- and Anesthesia-Related Complications;

Countries

China

Contacts

Public ContactLiqun Yang

Renji Hospital, Shanghai Jiao Tong University School of Medicine

Lqyang72721@126.com+86 21 6838 3364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026